“We’ve been able to increase lifespan by 30, 40, 50 percent by targeting the pathways that affect aging. Fundamentally, there’s no reason why that can’t be done in dogs,” Kaeberlein says.
Dog lover and biogerontologist Matt Kaeberlein has been experimenting with rapamycin, a drug commonly given to people receiving organ transplants. It helps prevent organ rejection.
But in mice, they’ve also found it does something extraordinary. It improved strength and cardiac function and considerably extended their lives. The “old man” in the mouse group, Ike, is the equivalent of a 140-year-old person.
So Kaeberlein looked at his own German shepherd Dobby and Keeshond Chloe, and thought, what if … And the Dog Aging Project was born. Kaeberlein and research partner Daniel Promislow opened up the study to a couple dozen dogs, including Rascal.
Some of the canine citizen scientists who have joined the study:
Whidbey is a 12 year old Golden Retriever.
Finn is a 10 year old German Shepherd mix
Read the full article here: kiro7.com